AUB ScholarWorks

Browsing by Subject "B cell lymphoma"

Browsing by Subject "B cell lymphoma"

Sort by: Order: Results:

  • Otrock Z.K.; Saab J.; Aftimos G.; Nasr F.; Farhat F.S.; Khairallah S.; Abadjian G.; Ghosn M.; Sidani H.; Ibrahim A.; Tawil A.; Ghorra C.; Meguerian Z.; Mokaddem W.; Dayeh W.; Salem Z.; Chahine G.; Bitar N.; Mugharbel A.; Makdessi J.; Khater C.; El Hajj M. (DORDRECHTVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS, 2013)
    Incidence of various Hodgkin (HL) and non-Hodgkin lymphoma (NHL) subtypes and association with viruses in Lebanon are not known. We undertook a nationwide study of 272 patients diagnosed with lymphoma in 2007. HL comprised ...
  • Charafeddine K.M.; Jabbour M.N.; Kadi R.H.; Daher R.T. (CHICAGO2100 W HARRISON ST, CHICAGO, IL 60612 USA, 2012)
    Serum free light chain (sFLC) assays were shown to improve detection, management, and prognostication in plasma cell disorders. Recently, sFLC assays improved detection of M proteins when combined with standard methods of ...
  • Saleh Z.; Kurban M.; Ghosn S.; Awar G.; Kibbi A.-G. (BASELALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, 2008)
    [No abstract available]
  • Saleh Z.; Kurban M.; Ghosn S.; Awar G.; Kibbi A.-G. (BASELALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, 2008)
    [No abstract available]
  • Saleh Z.; Kurban M.; Ghosn S.; Awar G.; Kibbi A.-G. (BASELALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, 2008)
    [No abstract available]
  • Bazarbachi A.; Hatoum H.A.; Mugharbel A.; Otrock Z.K.; Yassine N.; Muwakkit S.; Salem Z.; Shebbo W.; Jisr T.; Abboud M.; Ibrahim A. (LONDONMACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2008)
    Hematopoietic SCT (HSCT) has become a curative therapeutic strategy for several malignant and nonmalignant diseases. We report the comprehensive results of the first 10 years of experience in HSCT from the two major BMT ...
  • El Majzoub N.; Soweid A. (, 2013)
    [No abstract available]
  • El Majzoub N.; Soweid A. (, 2013)
    [No abstract available]
  • Kharfan-Dabaja M.A.; Nishihori T.; Otrock Z.K.; Haidar N.; Mohty M.; Hamadani M. (NEW YORK360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, 2013)
    Monoclonal antibodies are increasingly being incorporated in conditioning regimens for autologous or allogeneic hematopoietic cell transplantation (HCT). The benefit of adding rituximab to autologous HCT regimens is ...
  • Kharfan-Dabaja M.A.; Nishihori T.; Otrock Z.K.; Haidar N.; Mohty M.; Hamadani M. (NEW YORK360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, 2013)
    Monoclonal antibodies are increasingly being incorporated in conditioning regimens for autologous or allogeneic hematopoietic cell transplantation (HCT). The benefit of adding rituximab to autologous HCT regimens is ...
  • Kharfan-Dabaja M.A.; Nishihori T.; Otrock Z.K.; Haidar N.; Mohty M.; Hamadani M. (NEW YORK360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, 2013)
    Monoclonal antibodies are increasingly being incorporated in conditioning regimens for autologous or allogeneic hematopoietic cell transplantation (HCT). The benefit of adding rituximab to autologous HCT regimens is ...
  • El-Bitar M.K.; Muwakkit S.A.; Abboud M.R.; Sawaya R.A.; Boustany R.-M. (THOUSAND OAKS2455 TELLER RD, THOUSAND OAKS, CA 91320 USA, 2010)
    Morvan syndrome is a rare autoimmune disease named after the French physician Augustin Marie Morvan. It is characterized by multiple, irregular contractions of the long muscles, weakness, pruritus, hyperhidrosis, insomnia, ...
  • Musallam K.M.; Hatoum H.A.; Barada K.; Taher A.T.; Salem M.E.; Malek E.M.; Shamseddine A.I. (TOTOWA999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA, 2010)
    This study aimed at investigating the incidence, presentation, patient and tumor characteristics, treatment, and outcome of primary colorectal lymphomas (PCL) at a tertiary care center in LBN over a 25-year period. The ...
  • Musallam K.M.; Hatoum H.A.; Barada K.; Taher A.T.; Salem M.E.; Malek E.M.; Shamseddine A.I. (TOTOWA999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA, 2010)
    This study aimed at investigating the incidence, presentation, patient and tumor characteristics, treatment, and outcome of primary colorectal lymphomas (PCL) at a tertiary care center in LBN over a 25-year period. The ...
  • Musallam K.M.; Hatoum H.A.; Barada K.; Taher A.T.; Salem M.E.; Malek E.M.; Shamseddine A.I. (TOTOWA999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA, 2010)
    This study aimed at investigating the incidence, presentation, patient and tumor characteristics, treatment, and outcome of primary colorectal lymphomas (PCL) at a tertiary care center in LBN over a 25-year period. The ...
  • Kharfan-Dabaja M.A.; Cutler C.S. (TOKYO1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN, 2011)
    Growing understanding of the important role of B lymphocytes in alloreactivity has paved the way for evaluating anti-B cell therapy with rituximab in patients undergoing allogeneic hematopoietic cell transplantation. Data ...
  • Kharfan-Dabaja M.A.; Cutler C.S. (TOKYO1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN, 2011)
    Growing understanding of the important role of B lymphocytes in alloreactivity has paved the way for evaluating anti-B cell therapy with rituximab in patients undergoing allogeneic hematopoietic cell transplantation. Data ...
  • Kharfan-Dabaja M.A.; Cutler C.S. (TOKYO1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN, 2011)
    Growing understanding of the important role of B lymphocytes in alloreactivity has paved the way for evaluating anti-B cell therapy with rituximab in patients undergoing allogeneic hematopoietic cell transplantation. Data ...
  • Abbas O.; Mahalingam M. (PHILADELPHIA530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA, 2013)
    The grenz zone is a narrow area of the papillary dermis uninvolved by underlying pathology. Historically believed to be a feature unique to granuloma faciale, this feature has also been observed in other cutaneous inflammatory ...
  • Younes M.; Dagher G.A.; Dulanto J.V.; Njeim M.; Kuriakose P. (PHILADELPHIA530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA, 2013)
    OBJECTIVES: Macrocytosis is a relatively common finding in adult patients undergoing blood cell counting. Approximately 10percent of patients will have unexplained macrocytosis after laboratory evaluation. Data on the ...

Search AUB ScholarWorks

Browse

My Account